Nephroprotective
activity of Vigna mungo (Linn.)
Hepper on gentamicin-induced
renal damage in albino rats.
Nitin
M.1, Ifthekar S. 2*
Department of Pharmacology, H.K.E Society’s
College of pharmacy, Sedam road, Gulbarga – 585105,
Karnataka, India
ABSTRACT:
The present study was undertaken to investigate the
preliminary phytochemical studies and nephroprotective activity of aqueous and methanolic extracts of seeds of Vigna mungo in Gentamicin-induced
nephrotoxicity in rats. The seed powder of Vigna mungo was
successively extracted with methanol and water. Preliminary phytochemical
tests were done, the extracts showed the presence of amino acids, alkaloids,
ascorbic acid, carbohydrates, flavonoids, glycosides,
proteins, phytic acid, total phenolic
compounds, reducing sugars, saponins and tannins. The
protective activity of the extracts was justified by physical (decrease in body
weight) and biochemical (increased blood urea nitrogen, serum creatinine, serum uric acid and decreased serum total
protein) changes induced by gentamicin in kidney
parameters. When compared to normal control group. The groups treated with both
the extracts had significantly prevented the above changes produced by gentamicin in rats. In general both the extracts possessed
protective activity though methanolic extract was
found to exhibit greater protection.
KEYWORDS:
Gentamicin, Nephroprotective
Activity, Vigna mungo,
Phytochemistry.
INTRODUCTION:
Kidney is one of the important targets for the toxic
effects of drugs, xenobiotics and oxidative stress.
Oxygen free radicals have been implicated in several biological processes
potentially important in glomerular diseases.1,2
Gentamicin is an extensively used aminoglycoside
antibiotic for the treatment of gram negative bacterial infections. Nephrotoxicity is the major side effect of aminoglycosides, accounting for 10-15% of all cases of
acute renal failure.3 Previous studies have demonstrated, an
increase in renal cortical lipid peroxidation in gentamicin treated rats and in
vitro generation of hydrogen peroxide by renal cortical mitochondria.4,5
It has been reported that the use of hydroxyl scavengers may mitigate gentamicin-induced kidney function in rats.6
Vigna mungo
(Linn.) Hepper, Family Fabaceae
commonly known as black gram (Urid, Mash). The seeds
are extensively cultivated all over the India. It has been used for various
medicinal purposes in Ayurvedic and Unani systems of medicine. The seeds are sweet, laxative,
aphrodisiac, tonic, appetizer, diuretic, galactagogue
and styptic; useful in piles, asthma, scabies, leucoderma,
gonorrhea, pains, epistaxis, paralysis, rheumatism
and affections of the nervous system, liver and cough. It is also prescribed
for dropsy and cephalalgia.7 Oxygen free radicals have been
implicated in several biological processes potentially important in glomerular diseases.8 The Vigna mungo have been reported for its
antioxidant activity.9 The drug is found to be potent diuretic which
causes excretion of sodium and potassium. These observations made us to investigate
the plant material for its nephroprotective activity
in rats. However there are no scientific and methodical investigations so far
been reported in literature regarding their actions on kidney.
Table 1: Preliminary phytochemical screening of aqueous and methanolic
extracts of seeds of Vigna mungo.
|
Sl no. |
Tests |
AEVM |
MEVM |
Inference |
|
1 |
Tests
for alkaloids |
Alkaloids
present in both the extracts |
||
|
Dragendorff`s test |
++ |
++ |
||
|
Mayer`s
test |
+ |
+ |
||
|
Hager`s
test |
++ |
+ |
||
|
Wagner`s
test |
+ |
+ |
||
|
2 |
Tests
for carbohydrates and Glycosides |
Reducing
sugars and glycosides present in
aqueous extract. Non-reducing
sugars and glycosides present in Methanolic extract |
||
|
Molish`s test |
++ |
++ |
||
|
Fehling`s
test |
++ |
- |
||
|
Benedict`s
test |
++ |
- |
||
|
Hydrolyse (Fehling &
Benedict) |
+ |
++ |
||
|
Barfoed`s test |
++ |
+ |
||
|
3 |
Tests
for proteins |
Proteins
present in both the extracts |
||
|
Biuret`s test |
++ |
++ |
||
|
Million`s |
++ |
++ |
||
|
4 |
Tests
for Amino acids |
Amino
acids present in both the extracts,aqueous (low)
and Tryptophan in methanolic extract
|
||
|
Ninhydrin test |
+ |
++ |
||
|
Test
for tryptophan |
- |
++ |
||
|
Test
for cysteine |
- |
- |
||
|
5 |
Tests
for Phenolic compounds and tannins |
Phenolic compounds and tannins
present in both the extracts |
||
|
Fecl3
test |
++ |
++ |
||
|
Lead
acetate test |
++ |
++ |
||
|
Gelatin
test |
++ |
++ |
||
|
6 |
Tests
for Flavonoids |
|
|
Flavonoids present in both
extracts aqueous (low) |
|
Shinoda test |
++ |
++ |
||
|
Aqueous
NaOH |
+ |
++ |
||
|
Conc.
H2SO4 |
+ |
++ |
||
|
7 |
Tests
for Vitamin C (Ascorbic acid) |
Ascorbic
acid present in aqueous extract and
absent in methanolic ext. |
||
|
Sodium
nitroprusside test |
++ |
- |
||
|
Dichlorophenolindophenol
test |
++ |
- |
||
Table 2: Influence of methanolic (MEVM) and aqueous (AEVM) extracts of seeds of Vigna mungo on physical
and biochemical parameters against gentamicin-induced
nephrotoxicity in rats.
|
Group |
Treatment |
Dose |
Physical parameter |
Biochemical parameters |
|||
|
Change in wt. (g) |
BUN (mg/dl) |
Serum Creatinine (mg/dl) |
Serum Uric acid (mg/dl) |
Total Protein (g/dl) |
|||
|
1 |
Normal control |
Equivalent volumes (DW) |
8.17±0.70 |
22.85±1.08 |
0.54±0.02 |
2.64±0.20 |
5.23±0.06 |
|
2 |
GENT control |
80mg/kg (GENT) |
-13.83±0.60*** |
54.20±3.93*** |
1.90±0.03*** |
7.07±0.18*** |
3.50±0.14*** |
|
3 |
GENT + CYST |
80mg/kg + 500mg/kg |
4.50±0.43*** |
26.90±2.26*** |
0.67±0.02*** |
2.80±0.11*** |
5.57±0.16*** |
|
4 |
GENT+ AEVM |
80mg/kg + 500mg/kg |
4.33±0.42*** |
28.13±1.50*** |
0.66±0.04*** |
2.83±0.23*** |
5.34±0.21*** |
|
5 |
GENT+ MEVM |
80mg/kg + 500mg/kg |
5.67 ±0.33*** |
26.45±2.81*** |
0.55±0.34*** |
2.57±0.20*** |
5.71±0.29*** |
Values are
represented as Mean ± SEM; (n = 6).
***p<0.001 Gentamicin control Vs Normal control,
***p<0.001 (GENT
+ CYST), (GENT + AEVM) and (GENT + MEVM) Vs Gentamicin
control.
DW-Distilled
water, GENT-Gentamicin, CYST-Cystone
tablet, AEVM-Aqueous extract of seeds of Vigna
mungo, MEVM- Methanolic
extract of seeds of Vigna mungo.
MATERIALS AND METHODS:
Drugs and chemicals: Cystone tablets (Himalaya Cystone),
Gentamicin, were purchased from medical shop. The
kits for biochemical estimation were purchased from ERBA manufactured by Transasia Bio-medicals LTD. Baddi,
Dist: Solan, India (HP). The solvents and other
chemicals were obtained from the store of H.K.E. Society`s College of pharmacy
Gulbarga that were supplied by standard manufacturers.
Plant material and extraction:
The seeds of Vigna mungo (Linn.) Hepper were
purchased from the local market of Gulbarga, Karnataka; were authenticated at
Pharmacognosy department of HKES’s College of Pharmacy, Gulbarga.
For aqueous extract the powdered material was subjected
to maceration process with distilled water for 7 consecutive days with
occasional stirring. For methanolic extract the seeds
were powdered and defatted with petroleum ether and then subjected to
successive extraction with methanol (95%) using Soxhlet apparatus for 36 h.
After completion of extraction process both the extracts were evaporated at 60oC
on a water bath to have thick pasty mass referred to as seed extracts, the %
yield was 23 g. (aqueous extract) and 13 g. (methanolic
extract).
Phytochemical
screening:
Preliminary phytochemical screening
of MEVM was carried out as described by Khandelwal.10
Animals and housing
parameters:
Normal adult albino wistar
rats of either sex weighing 200-250 g. were used for this study. The rats were
procured from animal house of H.K.E.S`s College of Pharmacy Gulbarga. Standard
environmental conditions such as temperature (26±2o), relative
humidity (45-55%) and 12 h light and dark cycle were maintained in the
quarantine. Standard pelletised feed and water was
allowed ad libitum
under hygienic conditions. The animals were habituated to laboratory
conditions for 48 hour prior to the experimental protocol to minimize any
nonspecific stress. The Institutional Animal Ethics Committee of H.K.E.S`s
College of pharmacy, Gulbarga, India, approved the experimental protocol in
accordance with the guidelines provided by Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEA) with registration no.
142/1999 CPCSEA 5 TH July 1999.
Acute toxicity studies:
According to earlier reports the dose of Vigna mungo seed extract 500mg/kg body weight p.o. was used as Hepatoprotective.11 As Vigna mungo seeds
being used as food can be consumed in daily life therefore the above dose was
considered as non-toxic and hence used same dosage in this study.
Figure 1:
Influence of aqueous (AEVM) and methanolic (MEVM)
extracts of seeds of Vigna mungo on selected physical and serum biochemical
parameters in gentamicin-induced nephrotoxicity
in rats.
Nephroprotective
Activity:
Nephroprotective activity study was
carried out as described by Vijay.12 Albino rats of either sex (200-
250 g) were selected and divided in to five groups of six animals each.
Group 1: Normal control;
received equivalent volumes of vehicle (distilled water)
Group 2: Gentamicin control; received Gentamicin
(80 mg/kg/day i.p.) for 8 days.
Group 3: Standard;
received Cystone (500 mg/kg.p.o)
after 30 m. gentamicin (80 mg/kg/day i.p.)
Group 4: received AEVM (500 mg/kg.p.o.) after 30 m. gentamicin (80
mg/kg/day i.p.)
Group 5: received MEVM (500 mg/kg.p.o.)
after 30 m. gentamicin
(80 mg/kg/day i.p.)
The study was carried out for
8 days, Body weight was noted before and after 8 days. On 9th day
all the animals were anaesthetized by overdosage of
ether and sacrificed. The blood samples were collected by cardiac puncture
method and kidneys were dissected out immediately and transferred into 10%
formalin for its histopathological studies.13 The blood samples were centrifuged at 2500 rpm for 15 min. and then
subjected for the estimation of biochemical parameters such as Blood urea
nitrogen, serum creatinine, serum uric acid and serum
total proteins.
Figure 2:
Effect of aqueous (AEVM) and methanolic (MEVM)
extracts of seeds of Vigna mungo on histopathological
examination of rat kidney in gentamicin-induced nephrototoxicity.
a. Group 1 (Normal control): Showing normal
b. Group 2 (Gentamicin control): PC-
histology of rat kidney. Peritubular congestion and Inflammation.
Histopathological studies:
Histopathological studies of kidney
were performed in Farooqui histopathology laboratory
by consultant histopathologist.
Statistical analysis:
The data obtained in the
experiment were expressed in terms of mean ± SEM. Statistical significance of data was assessed by
one way analysis of variance (ANOVA) followed by a comparison between different
groups using “Tukey-Kramer” multiple comparison test.
A value of P<0.05 was considered
to be statistically significant. The gentamicin control
group was compared with the normal control group and all other treatment groups
were compared with the gentamicin control group.
c. Group 3 (Standard): CMC-Cortical mild congestion.
d. Group 4 (AEVM): MCON&I-Mild congestion and Inflammation.
e. Group 5
(MEVM): VMC-Very mild congestion.
RESULTS:
Preliminary phytochemical studies revealed the presence of amino acids, alkaloids, ascorbic acid,
carbohydrates, flavonoids, glycosides, proteins, phytic acid, phenolic compounds,
reducing sugars, saponins and tannins in aqueous
extract and the methanolic extract additionally
showed the presence of non reducing sugars, tryptophan and higher concentration
of amino acids and flavonoids (Table 1).
Parameters assessed for kidney functions:
The body weight of the rats
treated with gentamicin were found to be
significantly reduced as compared to normal control group and the groups
treated with cystone, AEVM and MEVM showed
significant elevation in body weight 4.50g, 4.33g and 5.67g respectively (Table
2, Figure 1).
Biochemical parameters such
as Blood urea nitrogen, serum creatinine, and serum
uric acid were found to be significantly increased and serum total protein was
significantly decreased in group treated with gentamicin
as compared to the normal control group. Whereas groups treated with cystone, AEVM and MEVM had significantly prevented the
above biochemical changes induced by gentamicin
compared to gentamicin control group (Table 2, Figure
1).
Histopathological studies:
Normal control group showed
the normal histology of rat kidney whereas gentamicin
control group showed cortical glomerular, peritubular, blood vessel congestion and interstitial
inflammation. Groups treated with cystone, AEVM and
MEVM were found to reduce such histological changes produced by gentamicin in rat’s kidney as shown in Figure 2.
DISCUSSION:
Aminoglycoside
antibiotics including gentamicin are widely used in
the treatment of gram-negative infections. However the major complication of
the use of these drugs is nephrotoxicity, accounting
for 10-15% of all cases of acute renal failure. The nephrotoxicity
of gentamicin is well established in man &
experimental animals. Renal tubular cell injury produced by gentamicin
evolves subacutely over several days & is
characterized by following
·
Cellular necrosis
·
Large lysosomes
& myeloid bodies
·
Mitochondrial structural
alteration like swollen & ruptured mitochondria,
·
Accumulation of gentamicin in renal proximal convoluted tubules.
·
Suppression of free radical defence mechanism
·
Phospholipidosis
Gentamicin in a dose of 80
mg/kg i.p. has already been shown to produce
nephrotoxicity.14 Various environmental toxicants and
clinically useful drugs, like acetaminophen and gentamicin,
can cause severe organ toxicities through the metabolic activation to highly
reactive free radicals including the superoxides and
oxygen reactive species.15 A
relationship between oxidative stress and nephrotoxicity
has been well demonstrated in many experimental animal models. Administration
of vitamin E significantly reduced the nephrotoxic
symptoms produced by adriamycin.16 In gentamicin
treated rats, there was a significant increase in lipid peroxidation
products (MDA) suggesting the involvement of oxidative stress. A role of lipid peroxidation in gentamicin-induced
acute renal failure has been described by evaluating the effect of diphenyl-phenylenediamine and vitamin E.17
Gentamicin enhances the production of hydrogen peroxide in
isolated mitochondria, Pretreatment
of rats with hydroxyl radical scavengers protects against gentamicin
induced acute renal failure.6
Phenolic acids, polyphenols
and flavonoids scavenge free radicals such as
peroxide, hydroperoxide or lipid peroxyl,
thus inhibiting the oxidative mechanism that lead to degenerative diseases.18,19
In the present study the group treated with only Gentamicin 80mg/kg body weight i.p.
produced nephrotoxicity
as evidenced by decrease in body weight, increase in blood urea nitrogen, serum
creatinine, serum uric acid and decrease in serum
total protein levels as compared to normal control group. On the other hand the
groups pretreated with AEVM and MEVM significantly increased body weight,
decreased blood urea nitrogen, serum creatinine,
serum uric acid and increased serum total protein levels as compared to gentamicin control group. The histological changes such as
cortical glomerular, peritubular
blood vessel congestion and interstitial inflammation produced by gentamicin were significantly prevented the groups
pretreated with AEVM and MEVM. All the histological changes observed were in
correlation with the physical and biological parameters of the kidney.
The aqueous and methanolic extracts showed the presence of potent
antioxidants such as ascorbic acid, polyphenols like flavonol glycosides, flavonoids,
total phenolic compounds, tannins, saponins etc. it has been reported that saponins
from Vigna mungo seeds
possess diuretic activity.20
Antioxidant activity.9 And
it has been proved that pedalium murex has a diuretic and antioxidant
activity possesses a nephroprotective activity
against cisplatin induced nephrotoxicit.16
CONCLUSION:
From the above summary it can
be concluded that due to the presence of strong antioxidant and potent diuretic
effect in the Vigna mungo, the
extracts possess a nephroprotective activity. Though methanolic extract showed greater activity than aqueous
extract.
ACKNOWLEDGEMENT:
The authors are thankful to
authorities of H.K.E.S and MTR institute of pharmaceutical Science for
providing the necessary facilities to carry out the work.
REFERENCES:
1.
Shah, S.V.
(1984). Effect of enzymatically generated reactive
oxygen metabolites on the cyclic nucleotide content in isolated glomeruli. J Clin Invest
74:393-401.
2.
Shah, S.V., Barcos, W.H., Basci, A. (1987).
Degradation of human glomerular basement membrane by
stimulated neutrophils. Activitation
of a metalloproteinase by reactive oxygen metabolite. J Clin
Invest 79:25-31.
3.
Homes, H.D.,
Weinberg, J.M. (1986). Toxic nephropathies. In: Kidney. Brenner, B.M., Rector,
F.C. Jr. (eds). Philadelphia, Saunders Co., 1491-533.
4.
Ramsammy, L.S., Josephowitz, C., Ling, K.Y., Lane, B.P., Kaloyanides, G.J. (1986). Effects of diphenyl-phenylenediamine
on gentamicin-induced lipid peroxidation
and toxicity in rats. J Pharmacol Exp Ther. 238:83-8.
5.
Walker, P.D.,
Shah, S.V. (1987). Gentamicin enhances production of
hydrogen peroxide by renal cortical mitochondria. J Physiol. 253:495-9.
6.
Walker, P.D.,
Shah, S.V. (1988). Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest. 81:334-41.
7.
Kirtikar, K.R. and Basu, B.D. (1993). Indian Medicinal plants. International
Book Distributors: Dehradun. 1:795-796.
8.
Rehan, A.K., Johnson, K.J.,
Kunkel, R.G., Wiggins, R.C. (1985). Role of oxygen radicals in phorbol mmyrstate acetate-induced
glomerular injury. Kidney Inter. 27:503-11.
9.
Manisha chikane,
R., Dilip parwate, V., Vishwas ingle, N., et
al. (2011). In vitro Antioxidant
effect of seed coat extracts of Vigna mungo Journal of pharmacy Research. 4(3):656-657.
10.
Khandelwal, K.R. (2000).
Practical pharmacognosy technique and experiments 9th
ed. Pune:
Nirali Prakashan.
149-55.
11.
Solanki, Y.B. and Jain, S.M.
(2011). Hepatoprotective activity of Clitoria ternatea and Vigna mungo against
Acetaminophen and CCl4-induced hepatotoxicity
in rats Journal of pharmacol and Toxi.
6(1):30-48.
12.
Vijay kumar, K., Naidu, M.U.R., Anwar shifow,
A., Ratnakar, K.S. (2000). Probucol
protects against gentamicin-induced nephrotoxicity in rats. Ind J Pharmacol. 32:108-113.
13.
Sakhae K, Adams-Huet B, Moe OW and Pak CC. Pathophysiologic
basis for normouricosuric uric acid nephrolithiasis, Kidney Int 2002;
62(3):971-979.
14.
Abdel-Gayoum, A.A., Ali, B.H., Abdel Razig,
K.M., Bashir, A.A., Ghywarsua,
K. (1994). Effect of gentamicin-induced nephrotoxicity on some carbohydrate metabolism pathways in
the rat renal cortex. Arch Toxicol. 68:643-7.
15.
Shyamladevi, C.S. and Devipriya, S. (1999). Indian J. Pharmacol.
31:422-426.
16.
Shelke, T.T., Kothari, R.
(2009). Nephroprotective activity of ethanolic extract of dried fruits of Peddlium murex Linn. J. Cell and Tissue Research 9(1):1687-1690.
17.
Ramsammy, L.S., Josephowitz, C., Ling, K.Y., Lane, B.P., Kaloyanides, G.J. (1987). Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin-induced nephrotoxicity in the rat. Biochem
Pharmacol. 36:2125-32.
18.
Yizhong, C., Luo,
Q., Mei, S., Corke, H. (2004). Antioxidant activity
and Phenolic compounds of 112 traditional Chinese
medicinal plants associated with anticancer. Life Sci. 74:2157-2184.
19.
Halvorsen, B.L., Calrsen, M.H., Philips, K.M., Bohn, S.K., et al. (2006). Content of redox-active compounds (i.e. antioxidants) in foods
consumed in the United States. Am J Clin. Nutr. 84:95-135.
20.
Chowdhurry, A.K.A., Jahioullah, I.J., Tabukder, S.A.,
Khan, A.K.A. (1987). Diuretic activities of saponins
of Vigna spp. J
Bangladesh Acad Sci. 11:75.
Received on 03.07.2012
Modified on 18.07.2012
Accepted on 27.07.2012
© A&V Publication all right
reserved
Research J. Pharmacology and
Pharmacodynamics. 4(5): September
–October, 2012, 299-303